Physician profile
William D Grainger
NPI 1003963679
$211,399.06
in general payments reported to CMS, 2019-2025
56 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $27K · 2021: $66K · 2022: $24K · 2023: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $1,821 · Food and Beverage: $223 · Consulting Fee: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,962.00 |
| Travel and Lodging | $1,821.00 |
| Food and Beverage | $222.62 |
| Consulting Fee | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $154,893.43 | 2019-2023 | Vumerity |
| Genentech USA, INC. | $17,640.81 | 2019-2022 | |
| Amgen INC. | $16,193.37 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $14,448.93 | 2019-2022 | |
| Celgene Corporation | $1,504.54 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $901.46 | 2019-2022 | |
| Allergan, INC. | $597.16 | 2019-2022 | |
| Emd Serono, INC. | $560.84 | 2019-2022 | |
| Abbvie INC. | $503.27 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $391.46 | 2019-2022 | |
| Ucb, INC. | $388.21 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $348.53 | 2019-2020 | |
| Lilly USA, LLC | $259.52 | 2019-2022 | |
| Csl Behring | $234.61 | 2020-2022 | |
| Genzyme Corporation | $190.22 | 2019-2020 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Grainger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.